Personalized Medicine: The Impact of Genomic Technologies on Rheumatoid Arthritis Treatment Use Cases and Future Comparison Standard Protocols
A defining market trend on the horizon for the Rheumatoid Arthritis drug market is the definitive shift toward personalized medicine, fundamentally driven by advances in specific technologies like genomic and transcriptomic profiling. The goal is to move away from empirical treatment choices toward predictive selection—matching the right product type to the right patient at the right...
0 Comments 0 Shares 802 Views 0 Reviews